ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,926.90
      -0.07%
      US Tech 100
      20,742.40
      -0.02%
      Dow Jones
      42,599.14
      -0.56%
      Brent Oil
      72.005
      -0.98%
      Bitcoin
      93,061.71
      -2.15%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Germany
      5. TG

      6. Valneva SE (AYJ) Quote

      Valneva SE

      Valneva SE (AYJ)

      TG
      1.90
      -0.061
      ( -3.11% )
      Updated: 11:08:46
      Realtime Data

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      1.90
      Bid
      1.899
      Ask
      1.913
      Volume
      104,817
      1.889 Day's Range 2.03
      1.724 52 Week Range 4.984
      Market Cap
      262.584M
      Previous Close
      1.961
      Open
      2.00
      Last Trade
      19
      @
      1.9
      Last Trade Time
      11:02:23
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      92,644
      Shares Outstanding
      138,202,132
      Dividend Yield
      -
      PE Ratio
      -2.58
      Earnings Per Share (EPS)
      -0.73
      Revenue
      175.73M
      Net Profit
      -101.43M

      About Valneva SE

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.valneva.com
      Headquarters
      Saint-herblain, Loire-atlantique, Fra
      Founded
      -
      Valneva SE is listed in the Pharmaceutical Preparations sector of the Tradegate (DE) with ticker AYJ. The last closing price for Valneva was 1.96 €. Over the last year, Valneva shares have traded in a share price range of 1.724 € to 4.984 €.

      Valneva currently has 138,202,132 shares outstanding. The market capitalization of Valneva is 271.01 € million. Valneva has a price to earnings ratio (PE ratio) of -2.58.

      Ask ADVFN Intelligence (AI)

      AYJ Latest News

      More News

      Valneva accroît l’accessibilité de son vaccin contre le chikungunya en Asie grâce à une collaboration avec le Serum Institute of India

      Valneva accroît l’accessibilité de son vaccin contre le chikungunya en Asie grâce à une collaboration avec le Serum Institute of India Saint-Herblain (France), Pune, (Inde), le 19 décembre 2024 –...

      December 19 2024
      UK Regulatory

      Valneva Successfully Expands Access to Asia for its Chikungunya Vaccine with Serum Institute of India

      Valneva Successfully Expands Access to Asia for its Chikungunya Vaccine with Serum Institute of India Saint-Herblain (France), Pune, (India), December 19, 2024 – Valneva SE (“Valneva” or “the...

      December 19 2024
      UK Regulatory

      VALNEVA - Declaration of shares and voting rights: November 30, 2024

      VALNEVA - Declaration of shares and voting rights: November 30, 2024 VALNEVA Declaration of shares and voting rights November 30, 2024______________________________________________________________...

      December 05 2024
      UK Regulatory

      Déclaration d'actions et de droits de vote de la société Valneva SE - novembre 2024

      Déclaration d'actions et de droits de vote de la société Valneva SE - novembre 2024 VALNEVA Déclaration d’actions et de droits de vote 30 novembre 2024________________________________________...

      December 05 2024
      UK Regulatory

      Valneva Announces Peer-Reviewed Publication on the Global Health and Economic Burden of Chikungunya in The British Medical Journal

      Valneva Announces Peer-Reviewed Publication on the Global Health and Economic Burden of Chikungunya in The British Medical Journal Saint-Herblain (France), December 4, 2024 – Valneva SE (Nasdaq:...

      December 04 2024
      UK Regulatory

      Valneva annonce la publication dans le British Medical Journal d’un article sur l’impact sanitaire et économique mondial du chikungunya

      Valneva annonce la publication dans le British Medical Journal d’un article sur l’impact sanitaire et économique mondial du chikungunya Saint-Herblain (France), le 4 décembre 2024 – Valneva SE...

      December 04 2024
      UK Regulatory

      Valneva Reports Positive Three-Year Antibody Persistence Data for its Single-Shot Chikungunya Vaccine IXCHIQ®

      Valneva Reports Positive Three-Year Antibody Persistence Data for its Single-Shot Chikungunya Vaccine IXCHIQ® Antibody levels remained high at 96% seroresponse in line with the two-year...

      December 03 2024
      UK Regulatory

      Valneva annonce des données positives sur la persistance des anticorps à trois ans pour son vaccin à dose unique contre le chikungunya, IXCHIQ®

      Valneva annonce des données positives sur la persistance des anticorps à trois ans pour son vaccin à dose unique contre le chikungunya, IXCHIQ® Les niveaux d’anticorps demeurent élevés avec un...

      December 03 2024
      UK Regulatory

      Valneva soumet à la FDA une demande d’extension d’indication pour son vaccin contre le chikungunya IXCHIQ®

      Valneva soumet à la FDA une demande d’extension d’indication pour son vaccin contre le chikungunya IXCHIQ® Avec pour objectif l’extension de l’utilisation aux adolescents et l’inclusion de la...

      November 26 2024
      UK Regulatory

      Valneva Submits Label Extension Application for its Chikungunya Vaccine, IXCHIQ®, to the U.S. FDA

      Valneva Submits Label Extension Application for its Chikungunya Vaccine, IXCHIQ®, to the U.S. FDA To potentially include adolescents and antibody persistence up to two years Saint Herblain...

      November 26 2024
      UK Regulatory
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.052.70270270271.852.29999991.7241561131.9103855DE
      4-0.148-7.22656252.0482.29999991.7241391651.91059972DE
      12-0.826-30.30080704332.7262.8261.724926442.18242232DE
      26-1.288-40.40150564623.1884.0981.724791102.62237649DE
      52-2.611-57.88073597874.5114.9841.724739563.11908732DE
      156-23.88-92.629945694325.7826.941.724438857.22522012DE
      260-1.195-38.61066235863.09529.61.7245249310.69174505DE

      AYJ - Frequently Asked Questions (FAQ)

      What is the current Valneva share price?
      The current share price of Valneva is 1.90 €
      How many Valneva shares are in issue?
      Valneva has 138,202,132 shares in issue
      What is the market cap of Valneva?
      The market capitalisation of Valneva is EUR 271.01M
      What is the 1 year trading range for Valneva share price?
      Valneva has traded in the range of 1.724 € to 4.984 € during the past year
      What is the PE ratio of Valneva?
      The price to earnings ratio of Valneva is -2.58
      What is the cash to sales ratio of Valneva?
      The cash to sales ratio of Valneva is 1.49
      What is the reporting currency for Valneva?
      Valneva reports financial results in EUR
      What is the latest annual turnover for Valneva?
      The latest annual turnover of Valneva is EUR 175.73M
      What is the latest annual profit for Valneva?
      The latest annual profit of Valneva is EUR -101.43M
      What is the registered address of Valneva?
      The registered address for Valneva is 6 RUE ALAIN BOMBARD, CAMPUS BIO-OUEST, SAINT-HERBLAIN, LOIRE-ATLANTIQUE, 44800
      What is the Valneva website address?
      The website address for Valneva is www.valneva.com
      Which industry sector does Valneva operate in?
      Valneva operates in the PHARMACEUTICAL PREPARATIONS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      0RARAPT Therapeutics Inc
      1.50 €
      (87.50%)
      		65.34k
      FWR0Yumy Candy Company Inc the
      0.044 €
      (76.00%)
      		1.88M
      4APApollo Minerals Ltd
      0.01 €
      (66.67%)
      		30
      NL8Genesis Ai Corp
      0.0394 €
      (47.01%)
      		223.98k
      E3O1Nexoptic Technology Corp
      0.026 €
      (40.54%)
      		2.84k
      WWTWater Ways Technologies Inc
      0.0045 €
      (-95.91%)
      		2.53k
      L7C2Windfall Geotek Inc
      0.0025 €
      (-70.59%)
      		40k
      QP9Atco Mining Inc
      0.003 €
      (-55.88%)
      		1.5k
      AWY0Percheron Therapeutics Ltd
      0.002 €
      (-55.56%)
      		155k
      0PV2Moovly Media Inc
      0.002 €
      (-55.56%)
      		500
      D7GNel ASA
      0.2469 €
      (-1.87%)
      		2.63M
      FWR0Yumy Candy Company Inc the
      0.044 €
      (76.00%)
      		1.88M
      DI6Distribuidora Internacional De Alimentacion SA
      0.017 €
      (1.80%)
      		1.83M
      JSISamhallsbyggnadsbolaget Norden AB
      0.386 €
      (8.46%)
      		1.79M
      RQ0DWave Quantum Inc
      7.53 €
      (18.32%)
      		1.62M

      Discussion

      View Full Feed
      mrfence mrfence 52 seconds ago
      Shorty's digging his grave
      FNMA
      LoveItInBishop LoveItInBishop 59 seconds ago
      LITM .4435
      LITM
      Techroemancer Techroemancer 1 minute ago
      $MGON Agreed. It's libel to damage the reputation of Jeffrey Williams with inaccuracies and misinformation that is being used to disparage a company with established intent of stock price manipulation. It will do much more harm to them than what they think. Libel is not protected under the 1st amend
      MGON
      chuck4345 chuck4345 1 minute ago
      I’m patiently waiting at 0001 for him to do it again
      GTCH
      JJZander JJZander 1 minute ago
      HLLK news out 
      HLLK
      weedtrader420 weedtrader420 2 minutes ago
      RUMBLE XRP RUM
      XRPUSD
      KIPK KIPK 2 minutes ago
      KASRMY...Watching,.... and Waiting.......& ...Waiting....... and Waiting....
      PHIL
      Hoghead7 Hoghead7 2 minutes ago
      Nice WTM, Exxonmobil is going to me everything Long investors have ever hoped for and then some
      FCEL
      JJZander JJZander 2 minutes ago
      News out  style="caret-color: rgb(68, 68, 68); color: rgba(68, 68, 68, 1); font-family: "Nunito Sans", Helvetica, Arial, sans-serif; font-size: 17.6px; font-weight: 700; background-color: rgba(255, 255, 255, 1)"JUBILEE INTEL ANNOUNCES STRATEGIC PARTNERSHIP WITH PERION AND ITS EXPANSION INTO EMAIL MA
      HLLK
      lighter than AIR lighter than AIR 2 minutes ago
      NENorth…the Amigo failed to mention some of his postings fall into that 99% unreliable category as well…

      We’re going to be just fine. These guys may be keeping too much from us, and it may take forever…but that’s because they are not caving in to pressure from the big boys.
      CBRF
      Golden Cross Golden Cross 2 minutes ago
      $LITM could really pop here past .45 break
      LITM
      sch100 sch100 2 minutes ago
      HYFI 0post on X:
      Deals That Power the Future 🌍
      HyFi is sourcing renewable energy assets for M&A deals—working behind the scenes to secure predevelopment-stage wind & solar projects for a Fortune 100 company
      BOPO
      BIOChecker4 BIOChecker4 3 minutes ago
      The same as the number of shares sold.
      AVXL
      primecomm primecomm 3 minutes ago
      $TNXP Major Reversal Coming $$$$$$
      TNXP
      Mark Mark 3 minutes ago
      $HCWC .93 keep this low floater on watch
      HCWC
      spartex spartex 4 minutes ago
      Proto, I found this quote in Dr. Lebby's last presentation you posted exceptionally important as well. These are the final checklists needed to take a new higher performance and disruptive technology/platform commercial into the Tier-1 Big Boyz industry. Appears we are literally ready for liftoff
      LWLG
      Gizzer211 Gizzer211 4 minutes ago
      Same here, adding these dips is great
      BBUZ
      10thMountain 10thMountain 4 minutes ago
      Lol. The share structure here is very low. Only 500,000,000 A/S. But nice try
      HLLK
      gp22 gp22 4 minutes ago
      $ASST: Could easily go InPlay $$ at any time right now. Easy crowd target as it starts to hit screens.
      ASST
      kayak_wench kayak_wench 4 minutes ago
      That is awesome! I thought I had seen the trials were going to be Indonesia. India is a much better location. If your wondering I'm not unhappy with my decision to divest and move everything to here. I did re-take a small position today to motivate me to keep an eye on it. Nothing like my old
      ELTP
      gp22 gp22 4 minutes ago
      $ASST: Could easily go InPlay $$ at any time right now. Easy crowd target as it starts to hit screens.
      ASST
      PlaySmart2020 PlaySmart2020 4 minutes ago
      Treat it as an investment. Nothing will happen in a day or two. The more you watch the more chances you might get fed up and make a mistake of selling it off. If you are positive like many of us then stick to it and put it in your mind that 2025 would be the year. Give it 1 more year and hopefully,
      HMBL
      ORCA ORCA 5 minutes ago
      I AM WAITING FOR YOUR SHARES.DROP THEM.
      Jimmy Buffets Sister

      Re: A deleted message

      Thursday, December 12, 2024 12:55:26 PM

      Post#
      134338
      of 134440
      Not to worry ORCA, if no positive news comes prior to Dec 30 as I assume it wo
      VPLM
      The_Edge The_Edge 5 minutes ago
      Been accumulating ggsm ..record volume and revenue, new president
      gawti88 gawti88 5 minutes ago
      LOL yep, but I don't respond to him anymore and blocked :-)
      CEOS

      Your Recent History

      TG
      AYJ
      Valneva
      BIT
      HLTW
      ETF
      LSE
      SDIG
      Ishs $ Sd
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads